GSK, Google parent company to make bioelectronic medicine : cbc

as mentioned in cbc

GSK, Google parent company to make bioelectronic medicine

GSK, Google parent company to make bioelectronic medicine

Pharmaceutical giant GlaxoSmithKline is forming a joint venture with a unit of Google's parent that will invest 540 million pounds ($714 million US) in the relatively new field of bioelectronic medicine.GSK and Verily Life Sciences, a subsidiary of Alphabet, have agreed to create a new company known as Galvani Bioelectronics, which will be based in Britain.GSK said Monday that it will own 55 per cent of the venture, with Verily owning the rest.Bioelectronics seeks to treat chronic illnesses using tiny implants to change electronic signals that pass along nerves in the body.


let alone cityam

Google parent Alphabet's life sciences arm Verily and GSK are teaming up and investing millions into bioelectronics

Google parent Alphabet's life sciences arm Verily and GSK are teaming up and investing millions into bioelectronics

Lynsey BarberGoogle's parent company Alphabet and pharma firm GSK are banding together to form a new company that will explore the science behind using small electronics to treat disease.The pair will plough £540m over the next seven years into Galvani Bioelectronics, which will explore technology which combines electronics and biology to treat illnesses, with headquarters in the UK.Alphabet's Verily Life Science, which was formerly known as Google's Life Sciences division before the creation of the Google holding company, will have a 45 per cent stake in the company and GSK a majority 55 per cent stake.Read more: Google spins off life sciences division under AlphabetGSK has been working in the new field since 2012 and believes it can help to treat chronic conditions such as arthritis, diabetes and asthma.


in addition reuters

GSK and Google parent forge $715 million bioelectronic medicines firm

GSK and Google parent forge $715 million bioelectronic medicines firm

A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008.LONDON GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.Verily Life Sciences - known as Google's life sciences unit until last year - and Britain's biggest drugmaker will together contribute 540 million pounds ($715 million) over seven years to Galvani Bioelectronics, they said on Monday.The new company, owned 55 percent by GSK and 45 percent by Verily, will be based at GSK's Stevenage research center north of London, with a second research hub in South San Francisco.